Patient Portal

Clifford G. Robinson, MD

Assistant Professor, Radiation Oncology
Chief of Service, Stereotactic Body Radiation Therapy (SBRT)

Specialty Areas

Brain Tumors
Gamma Knife
Thoracic Oncology
Neuro Oncology
Radiation Oncology

Board Certifications

Radiation Oncology

Hospital Affiliations

Barnes-Jewish Hospital
Barnes-Jewish West County Hospital

Areas of Clinical Interest

Lung cancer, esophageal cancer, brain tumor, spine tumor, gamma knife, stereotactic body radiation therapy

  • Location(s)
  • Education
  • Publication & Research
  • Financial Disclosures

Location(s)

Location(s)

Center for Advanced Medicine

4921 Parkview Place
St. Louis, MO 63110

Floor: LL
Office Phone: 314-747-7236
Fax: 314-362-7769

Barnes-Jewish West County Hospital
Medical Building Two

10 Barnes West Drive
Creve Coeur, MO 63141

Office Phone: 314-996-3335
Fax: 314-996 3338

Education

Education

Medical Degree: Case Western Reserve University School of Medicine, Cleveland, Ohio 2004
Residency : Radiation Oncology, Cleveland Clinic, Cleveland, OH 2009
Chief Resident: Radiation Oncology, Cleveland Clinic, Cleveland, OH 2008
B.S. (Molecular Biology): University of Pittsburgh, Pittsburgh, PA 2000

Publication & Research

Publication & Research

Implementing a Novel Remote Physician Treatment Coverage Practice for Adaptive Radiation Therapy During the Coronavirus Pandemic.
Price A, Kim H, Henke LE, Knutson NC, Spraker MB, Michalski J, Hugo GD, Robinson CG, Green O
Adv Radiat Oncol. 2020 Jul-Aug; 5(4)737-742. doi: 10.1016/j.adro.2020.05.007.

PMID:
    32775784
    [PubMed]
Related citations


Impact of invasive nodal staging on regional and distant recurrence rates after SBRT for inoperable stage I NSCLC.
Kennedy WR, Samson PP, Gabani P, Nikitas J, Bradley JD, Roach MC, Robinson CG
Radiother Oncol. 2020 Jul 3; 150206-210. doi: 10.1016/j.radonc.2020.06.043.

PMID:
    32622780
    [PubMed - as supplied by publisher]
Related citations


Challenges in Re-Irradiation in the Thorax: Managing Patients with Locally Recurrent Non-Small Cell Lung Cancer.
Fischer-Valuck BW, Robinson CG, Simone CB 2nd, Gomez DR, Bradley JD
Semin Radiat Oncol. 2020 Jul; 30(3)223-231. doi: 10.1016/j.semradonc.2020.02.001.

PMID:
    32503787
    [PubMed - in process]
Related citations


Immunotherapy and Radiation Therapy for Non-Small Cell Lung Cancer-A Stimulating Partnership.
Dams RV, Yuan Y, Robinson CG, Lee P
Semin Respir Crit Care Med. 2020 Jun; 41(3)360-368. doi: 10.1055/s-0039-3399578.

PMID:
    32450590
    [PubMed - in process]
Related citations


Hippocampal-Sparing Radiotherapy for Patients With Glioblastoma and Grade II-III Gliomas.
Verma V, Robinson CG, Rusthoven CG
JAMA Oncol. 2020 May 14; doi: 10.1001/jamaoncol.2020.0164.

PMID:
    32407497
    [PubMed - as supplied by publisher]
Related citations


Astrovirus infects actively secreting goblet cells and alters the gut mucus barrier.
Cortez V, Boyd DF, Crawford JC, Sharp B, Livingston B, Rowe HM, Davis A, Alsallaq R, Robinson CG, Vogel P, Rosch JW, Margolis E, Thomas PG, Schultz-Cherry S
Nat Commun. 2020 Apr 29; 11(1)2097. doi: 10.1038/s41467-020-15999-y.

PMID:
    32350281
    [PubMed - indexed for MEDLINE]
Related citations


Implementation of a Novel Remote Physician SBRT Coverage Process during the Coronavirus Pandemic.
Price A, Henke LE, Maraghechi B, Kim T, Spraker MB, Hugo GD, Robinson CG, Knutson NC
Adv Radiat Oncol. 2020 Apr 28; doi: 10.1016/j.adro.2020.04.012.

PMID:
    32346656
    [PubMed]
Related citations


Cardiac radioablation-A systematic review.
van der Ree MH, Blanck O, Limpens J, Lee CH, Balgobind BV, Dieleman EMT, Wilde AAM, Zei PC, de Groot JR, Slotman BJ, Cuculich PS, Robinson CG, Postema PG
Heart Rhythm. 2020 Aug; 17(8)1381-1392. doi: 10.1016/j.hrthm.2020.03.013.

PMID:
    32205299
    [PubMed - in process]
Related citations


Schizophrenia-related microdeletion causes defective ciliary motility and brain ventricle enlargement via microRNA-dependent mechanisms in mice.
Eom TY, Han SB, Kim J, Blundon JA, Wang YD, Yu J, Anderson K, Kaminski DB, Sakurada SM, Pruett-Miller SM, Horner L, Wagner B, Robinson CG, Eicholtz M, Rose DC, Zakharenko SS
Nat Commun. 2020 Feb 14; 11(1)912. doi: 10.1038/s41467-020-14628-y.

PMID:
    32060266
    [PubMed - indexed for MEDLINE]
Related citations


Local consolidative therapy for oligometastatic non-small cell lung cancer.
Samson PP, Spraker MB, Badiyan SN, Vlacich G, Robinson CG, Chaudhuri AA
J Thorac Dis. 2019 Dec; 11(12)5649-5651. doi: 10.21037/jtd.2019.11.19.

PMID:
    32030290
    [PubMed]
Related citations


Oligoreview of Non-Small Cell Lung Cancer Oligometastases.
Giuliani ME, Robinson CG, Salama JK, Daly ME
Int J Radiat Oncol Biol Phys. 2020 Mar 1; 106(3)455-459. doi: 10.1016/j.ijrobp.2019.11.009.

PMID:
    32014142
    [PubMed - indexed for MEDLINE]
Related citations


Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.
Bradley JD, Hu C, Komaki RR, Masters GA, Blumenschein GR, Schild SE, Bogart JA, Forster KM, Magliocco AM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, Koprowski CD, Olson MR, Meng J, Paulus R, Curran WJ Jr, Choy H
J Clin Oncol. 2020 Mar 1; 38(7)706-714. doi: 10.1200/JCO.19.01162.

PMID:
    31841363
    [PubMed - in process]
Related citations


Recent advances in Merkel cell carcinoma.
Robinson CG, Tan D, Yu SS
F1000Res. 2019; 8pii: F1000 Faculty Rev-1995. doi: 10.12688/f1000research.20747.1.

PMID:
    31824653
    [PubMed - indexed for MEDLINE]
Related citations


High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539.
Rogers CL, Won M, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Fogh SE, Youssef E, Deb N, Kwok Y, Robinson CG, Shu HK, Fisher BJ, Panet-Raymond V, McMillan WG, de Groot JF, Zhang P, Mehta MP
Int J Radiat Oncol Biol Phys. 2020 Mar 15; 106(4)790-799. doi: 10.1016/j.ijrobp.2019.11.028.

PMID:
    31786276
    [PubMed - indexed for MEDLINE]
Related citations


Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933.
Bovi JA, Pugh SL, Sabsevitz D, Robinson CG, Paulson E, Mehta MP, Gondi V, Kundapur V, Shahin MS, Chao ST, Machtay M, DeNittis AS, Laack NN, Greenspoon JN, Moore KN, Huang J, Dominello MM, Kachnic LA
Adv Radiat Oncol. 2019 Oct-Dec; 4(4)579-586. doi: 10.1016/j.adro.2019.07.006.

PMID:
    31673651
    [PubMed]
Related citations


The transformation of radiation oncology using real-time magnetic resonance guidance: A review.
Hall WA, Paulson ES, van der Heide UA, Fuller CD, Raaymakers BW, Lagendijk JJW, Li XA, Jaffray DA, Dawson LA, Erickson B, Verheij M, Harrington KJ, Sahgal A, Lee P, Parikh PJ, Bassetti MF, Robinson CG, Minsky BD, Choudhury A, Tersteeg RJHA, Schultz CJ, MR Linac Atlantic Consortium and the ViewRay C2T2 Research Consortium.
Eur J Cancer. 2019 Nov; 12242-52. doi: 10.1016/j.ejca.2019.07.021.

PMID:
    31614288
    [PubMed - indexed for MEDLINE]
Related citations


Response by Robinson et al to Letter Regarding Article, "Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia".
Robinson CG, Knutson NC, Samson PP, Cuculich PS
Circulation. 2019 Jul 2; 140(1)e3-e4. doi: 10.1161/CIRCULATIONAHA.119.040793.

PMID:
    31549873
    [PubMed - indexed for MEDLINE]
Related citations


Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRT.
Kennedy WR, Gabani P, Nikitas J, Robinson CG, Bradley JD, Roach MC
Radiother Oncol. 2020 Jan; 142230-235. doi: 10.1016/j.radonc.2019.08.010.

PMID:
    31481272
    [PubMed - in process]
Related citations


Radiation Toxicity in Lung Cancer Patients: The Heart of the Problem?
Badiyan SN, Robinson CG, Bradley JD
Int J Radiat Oncol Biol Phys. 2019 Jul 1; 104(3)590-592. doi: 10.1016/j.ijrobp.2019.03.007.

PMID:
    31162057
    [PubMed - indexed for MEDLINE]
Related citations


Characterization and validation of an intra-fraction motion management system for masked-based radiosurgery.
Knutson NC, Hawkins BJ, Bollinger D, Goddu SM, Kavanaugh JA, Santanam L, Mitchell TJ, Zoberi JE, Tsien C, Huang J, Robinson CG, Perkins SM, Dowling JL, Chicoine MR, Rich KM, Dunn GP, Mutic S
J Appl Clin Med Phys. 2019 May; 20(5)21-26. doi: 10.1002/acm2.12573.

PMID:
    31055877
    [PubMed - indexed for MEDLINE]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2019:

Company Name: Radialogica

Royalties:

Equity: Yes

Consulting/Advisory Board: $20,000 - $39,999

Speaker Fees:

Reporting Date: May 01, 2020


Company Name: AstraZeneca

Royalties:

Equity: No

Consulting/Advisory Board: $60,000 - $79,999

Speaker Fees:

Reporting Date: May 01, 2020